Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(17/week)
Canada
(12/week)
Haiti
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
View all
(29/week)
News
United States
(1301/week)
Manufacturing
(724/week)
Energy
(519/week)
Technology
(1265/week)
Other Manufacturing
(494/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Bioterrorism
May 11, 2020
Soligenix Announces Publication of Correlates of Immune Protection for the RiVax® Ricin Toxin Vaccine
Apr 28, 2020
PathSensors, Inc Announced a New Air Sampling Invention
Apr 21, 2020
Global Biodefense Market is Expected to Reach $8.85 Billion by 2027
Mar 25, 2020
2020 Virology & Bacteriology Industry Insights - The Threat of Bioterrorism is Among the Main Driving Forces
Feb 13, 2020
FDA Grants Soligenix "Fast Track" Designation for RiVax® in the Prevention of Ricin Poisoning
Dec 12, 2019
Soligenix Initiates Clinical Trial of its Heat Stable Ricin Toxin Vaccine
Jun 13, 2019
Soligenix to Present RiVax® Program at the 13 Annual CounterACT Network Research Symposium
May 29, 2019
BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent
Apr 15, 2019
Zeteo Tech Awarded $6.5M DHS S&T Contract to Develop and Test digitalMALDI(TM) Real-Time Biological Threat Detection Technology
Dec 14, 2018
The Global Market for Anthrax Treatment (2019-2023) - Bayer, Elusys Therapeutics and Emergent BioSolutions are the Leading Players
Nov 12, 2018
Soligenix Selected to Present RiVax® Data at the Fourth International Conference on Vaccines Research & Development in Baltimore, Maryland
Oct 03, 2018
Ricin suspected in mail sent to Trump, Pentagon
Oct 02, 2018
Ricin suspected in mail sent to White House, Pentagon
Sep 04, 2018
Soligenix Announces Publication of Positive Long-Term Data Supporting Thermostability and Conformational Integrity of the RiVax® Ricin Toxin Vaccine
Aug 07, 2018
Global Biodefense Market Analysis, Growth, Trends & Forecast 2018-2023, With an Expected CAGR of 6.5% - ResearchAndMarkets.com
Jul 26, 2018
Soligenix Announces a RiVax® Program Presentation at the 31st Annual Congress on Vaccines, Clinical Trials & B2B in Vancouver, Canada
Jul 09, 2018
Soligenix Receives European and Canadian Patents for its Ricin Toxin Vaccine (RiVax®) Formulation
Mar 15, 2018
Soligenix Announces Recent Accomplishments And Year-End 2017 Financial Results
Jan 09, 2018
Appili Therapeutics Licenses Bioterrorism Vaccine Rights
Dec 21, 2017
Soligenix Identifies Biomarkers for Ricin Toxin Vaccine Testing under the FDA Animal Rule
Page 1
››
Latest News
Jul 27, 2024
LuxCreo Expands Partnership with ASICS to Make Personalized Shoes Accessible to Everyone
Jul 27, 2024
Smith Foundry Shutting Down Minnesota Facility
Jul 27, 2024
Fonon Corporation Quartz Laser Welding Benefits Glass Manufacturers
Jul 27, 2024
Pioneer Power Announces Filing of Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023
Jul 27, 2024
Kim calls for 'people's paradise' on Korean War anniversary
Jul 27, 2024
Philippines says 'no incidents' as it resupplies hotspot reef
Jul 27, 2024
Alliance Resource Partners, L.P. Declares Quarterly Distribution of $0.70 Per Unit; Announces Robinson...
Jul 27, 2024
EnerSys Completes Acquisition Of Bren-Tronics To Expand Presence In Critical Defense Applications
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
View All Events